Posted on May 11th, 2018 in
Events
Ubiquigent will be attending Bio 2018 (Boston, June 4th - 7th) to discuss how we enable and support ubiquitin system drug discovery. Our biology and chemistry platforms allow us to design and develop novel compounds targeted towards ubiquitin system proteins as…
Read more
Posted on April 5th, 2018 in
News
Dundee, UK, 5th April 2018: Ubiquigent Limited announced today that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. Under the terms of the collaboration…
Read more
Posted on March 30th, 2018 in
Events
'Chemical Libraries to Unlock Deubiquitylase (DUB) Targeted Drug Discovery' Ubiquigent's Scientific Director Dr Jason Brown will be presenting at the CHI Drug Discovery Chemistry conference in San Diego on Thursday 5th April 2018: 'Chemical Libraries to Unlock Deubiquitylase (DUB) Targeted…
Read more
Posted on January 16th, 2018 in
News
Posted on November 29th, 2017 in
Events
“PROTACs – An exciting therapeutic modality” Ubiquigent will be attending and presenting at the upcoming ELRIG networking event, organised in association with AstraZeneca The event is free to attend and will be held at the Alderley Park Conference Centre on…
Read more
Posted on November 29th, 2017 in
Events
Ubiquigent will be attending and presenting at the upcoming GTC - Enzymes in Drug Discovery Summit, which will take place on February 22nd-23rd, 2018 in San Diego, CA. Jason Brown (Scientific Director), will present an overview of Ubiquigent's activities in…
Read more
Posted on October 30th, 2017 in
Events
Ubiquigent will be attending the upcoming Bio Europe meeting (November 6-8, 2017), Berlin. If you’d like to discuss how our approach can support your ubiquitin-focused drug discovery projects please contact us via the partnering portal. For full details of the…
Read more
Posted on September 21st, 2017 in
Events
Ubiquigent will be attending and presenting at the upcoming Discovery on Target meeting (September 25– 29, 2017), Boston, MA. Come and see Jason Brown (Scientific Director) discuss ‘An Integrated Chemistry and Assay Platform to Enable and Support Ubiquitin-System Targeted Drug…
Read more
Targeting kinase enzymes has grown to dominate drug discovery over the last decade, accounting for 30% of current pharma R&D Click on the link below to download our brochure detailing "The Unbiquitin System" and how "The analogous ubiquitin cell signalling…
Read more
The first compound library comprising novel small molecules designed to target deubiquitylase enzymes Click on the link below to download a non-confidential summary of DUBtarget™-001 which includes details of how the library was designed and characterised by screening it using…
Read more
